Ochsner Health and MD Anderson expand advanced cancer care to Slidell Memorial Hospital, bringing new therapies and clinical ...

A study out of UF and MD Anderson Cancer Center shows patients with advanced lung or skin cancer taking certain drugs lived ...

Cancer patients receiving a certain type of immunotherapy were twice as likely to be alive after three years if they received ...

A multicenter Phase II clinical trial led by researchers at The University of Texas MD Anderson Cancer Center demonstrated ...

WASHINGTON (AP) — The most widely used COVID-19 vaccines may offer a surprise benefit for some cancer patients – revving up ...

Adult cancer patients from New Orleans to Baton Rouge and across the Northshore now have access to one of the nation’s most ...

Naval Daver, MD, who leads a number of acute myeloid leukemia (AML) research trials at MD Anderson Cancer Center in Houston, looks forward to a future where the treatment for AML is truly personalized ...

Immunotherapy has been one of the most promising advancements in cancer treatment. However, consistency in immunotherapy ...

Researchers at UF Health and the University of Texas MD Anderson have found that cancer patients may live longer if they receive the COVID-19 mRNA vaccine.

A nationally recognized cancer treatment network with a footprint across the nation is now coming to the Slidell area.

Patients with advanced lung or skin cancer who received a COVID-19 mRNA vaccine within 100 days of starting immunotherapy ...

Dr. Hagop Kantarjian, the acclaimed clinician and researcher at The University of Texas MD Anderson Cancer Center, is stepping down as chair of the hospital’s leukemia department after more than 30 ...